N-Myc (2) Antibody sc-142 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemN-Myc (2) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-142
Antibody TypePrimary Antibodies
NCBI Gene AliasesNmyc1, NMYC, bHLHe37, MYCNsORF, MYCNsPEP, c-nmyc, MODED, Nmyc, N-myc, ODED, Nmyc-1
Quantity200 µg/ml
ApplicationsWB, IP, IF
Reactivitymouse, rat, human
ClonalityMonoclonal
Clone2
Conjugate/TagUnconjugated
FormatPurified
Hostmouse
NCBI Full Gene NameMYCN proto-oncogene, bHLH transcription factor, v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived
TargetN-Myc
IsotypeIgG2a

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Cancer-associated fibroblasts promote tumor progression in fusion-positive rhabdomyosarcomaSci RepOctober 23, 2025Patrick Sipila, Son Tran, Chunfen Zhang, David Douglass, Anne-Marie Langevin, Aru NarendranUSA), β-Actin (1:1000; sc-47778), CXCR4 (1:1000; sc-53534), FOXO1 (1:1000; sc-374427), N-Myc (1:1000; sc-142), PDGFR-β (1:1000; sc-374573), PD-L1 (1:1000; #13684, Cell Signaling Technology, Danvers, MA, USA),

(2) MYC-Mediated Inhibition of ARNT2 Uncovers a Key Tumor Suppressor in GlioblastomaResearch SquareAugust 28, 2024Maralice Conacci-Sorrell, Yi-Heng Borenstein-Auerbach, Anthony Borenstein-Auerbach, Anthony Grichuk, M. Carmen Lafita-Navarro, M. Carmen Lafita-Navarro, Pedro Nogueira, Jiwoong Nogueira, Jiwoong Kim, Jerry W. Shay, et al.K27),Abcam,ab6002 AHRR,Abcam,ab108518 MAX,Santa Cruz,sc-197 MNT,Santa Cruz,sc-769 MYCN,Santa Cruz,SC-142 Nestin,Santa Cruz,sc-23927 GFAP,Cell Signaling,12389 Acetylated Tubulin,Sigma,T7451 α-Tubulin,Sigma,T6199 Phospho-p70

(3) Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistanceScience advancesOctober 28, 2022Mañas A, Aaltonen K, Andersson N, Hansson K, Adamska A, Seger A, Yasui H, van den Bos H, Radke K, Esfandyari J, et al.tris-buffered saline. The primary antibodies used were against MYCN (1:100; Santa Cruz Biotechnology, sc-142) and PHOX2B (1:100; Abcam, ab183741). The secondary antibodies used were Alexa Fluor 488 (1:200; Invitrogen,

(4) Overexpression of leucine aminopeptidase 3 contributes to malignant development of human esophageal squamous cell carcinomaJournal of molecular histologyJune 1, 2014Zhang S, Yang X, Shi H, Li M, Xue Q, Ren H, Yao L, Chen X, Zhang J, Wang H.

(5) SUMOylation of Myc-family proteinsPloS oneJanuary 1, 2014Sabò A, Doni M, Amati B.Abcam), Flag M2 (Sigma), HA (HA.11, Covance), SUMO-1 S8070 (Sigma), SUMO-2 (ab22654, Abcam), N-myc (2) (sc-142, Santa Cruz), N-Myc M50 (sc-22836, Santa Cruz), Vinculin (V9264, Sigma), p19-ARF 5-C3-1 (sc-32748, Santa Cruz

(6) Potential synergism of Bim with p53 in mice with Myc‑induced lymphoma in a mouse lymphoma modelMolecular medicine reportsJune 1, 2012Shang Q, Zhang D, Guo C, Lin Q, Guo Z, Deng C.Bim-long (L), Bim-short (S) (1:150, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-Puma, anti-Myc (#sc-142), anti-Bcl-2, anti-phosphorylated Bcl-2 that recognizes epitope Ser 87 (1:40, Santa Cruz Biotechnology),

(7) Effect of cytotoxic agents and retinoic acid on Myc-N protein expression in neuroblastomaApplied immunohistochemistry & molecular morphology : AIMMJanuary 1, 2010Aktas S, Altun Z, Erbayraktar Z, Aygun N, Olgun N.

(8) Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomasJournal of the National Cancer InstituteMay 6, 2009Chayka O, Corvetta D, Dews M, Caccamo AE, Piotrowska I, Santilli G, Gibson S, Sebire NJ, Himoudi N, Hogarty MD, et al.I-19, product sc-1616; Santa Cruz Biotechnology, Santa Cruz, CA); antiMYCN, mouse monoclonal (product sc-142; Santa Cruz Biotechnology); anti-clusterin-a, goat polyclonal (clone M-18, product sc-6420; Santa Cruz Biotechnology

(9) Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastomaJournal of pediatric surgeryNovember 1, 2007Fukahori S, Yano H, Tsuneoka M, Tanaka Y, Yagi M, Kuwano M, Tajiri T, Taguchi T, Tsuneyoshi M, Kojiro M.

(10) Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomasBrain & developmentJune 1, 2007Jozwiak J, Kotulska K, Grajkowska W, Jozwiak S, Zalewski W, Oldak M, Lojek M, Rainko K, Maksym R, Lazarczyk M, et al.

(11) Myc influences global chromatin structureThe EMBO journalJune 21, 2006Knoepfler PS, Zhang XY, Cheng PF, Gafken PR, McMahon SB, Eisenman RN.07-473, HP1a: 05-689, p300: 05-257, TIP60: 07-389, CBP: 06-294), except N-Myc (Santa Cruz; SC-791 and SC-142), GCN5 (Abcam 18381), and mAb AcH3 (Abcam 12179). A 1:500 dilution was used in each case. Mean fluorescence

(12) Increased HEXIM1 expression during erythroleukemia and neuroblastoma cell differentiationJournal of cellular physiologyMarch 1, 2006Turano M, Napolitano G, Dulac C, Majello B, Bensaude O, Lania L.

(13) Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2CancerNovember 1, 2004Kim MK, Carroll WL.

(14) Nestin is a potential mediator of malignancy in human neuroblastoma cellsThe Journal of biological chemistryJuly 2, 2004Thomas SK, Messam CA, Spengler BA, Biedler JL, Ross RA.

(15) Cellular models of drug- and radiation-resistant small cell lung cancerAnticancer researchMarch 1, 2004Davey RA, Locke VL, Henness S, Harvie RM, Davey MW.

(16) Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expressionInternational journal of radiation oncology, biology, physicsNovember 1, 2002Henness S, Davey MW, Harvie RM, Davey RA.

(17) Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIa expressionInternational Journal of Radiation Oncology, Biology, PhysicsJune 26, 2002Sheridan Henness B.Sc., Mary W Davey Ph.D., Rozelle M Harvie, Ross A Davey Ph.D.

(18) Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expressionCancer researchApril 1, 2001Iyengar RV, Pawlik CA, Krull EJ, Phelps DA, Burger RA, Harris LC, Potter PM, Danks MK.

Be the First to Write a Review!

N-Myc (2) Antibody

N-Myc (2) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (18)

Reviews

N-Myc (2) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map